Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2024-10-01

Clinical Trial Update: Fosfomycin I.v. for Treatment of Severely Infected Patients

View source ↗

Summary

An intravenous fosfomycin trial is recruiting to evaluate its use in severely infected patients across multiple bacterial infection indications.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Fosfomycin IV (fosfomycin)

Snippet

Sponsor: Infectopharm Arzneimittel GmbH | Conditions: Bacterial Infections, Bone Diseases, Infectious | Status: RECRUITING